Trials / Sponsors / G2GBio, Inc.
G2GBio, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscul Alzheimer Disease | Phase 1 | 2024-01-03 |
| Completed | Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Pain, Postoperative | Phase 1 | 2023-10-24 |
| Completed | Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose o Alzheimer Disease | Phase 1 | 2022-08-26 |